BACE1 inhibitor peptides
US10947272B2 · kind B2 · utility
0Cited by
2References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 21, 2016 |
| Grant date | Mar 16, 2021 |
| Priority date | — |
| Expiry date | Jul 13, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to dual-site BACE1 inhibitors, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.